Antitrust Issues with Biologics and Biosimilars in the US and Europe - March 10, 2020

The panel will compare and contrast antitrust issues associated with biologics and biosimilars in the US and Europe. We will have a diverse panel from the defense, plaintiff, in-house, and government perspective that will discuss recent cases, enforcement efforts, and best practices from a counseling perspective.

Premium Content For:
  • Antitrust Law Section
Join - Now